# BIODEXA PHARMACEUTICALS PLC (BDRX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BDRX/

- Reporting holders: 8
- Reported value: $48.1K
- Shares held by institutions: 16,569 of 225,817,808,922 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $43.1K | 14,809 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $3.5K | 1,203 | 0.0% | 1 |
| [Allied Private Wealth LLC](https://holderbook.com/funds/2132253-allied-private-wealth-llc/) | $1.3K | 489 | 0.0% | 1 |
| [SBI Securities Co., Ltd.](https://holderbook.com/funds/1851815-sbi-securities-co-ltd/) | $84 | 29 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $73 | 25 | 0.0% | 1 |
| [Hilton Head Capital Partners, LLC](https://holderbook.com/funds/2109913-hilton-head-capital-partners-llc/) | $17 | 6 | 0.0% | 1 |
| [Caitong International Asset Management Co., Ltd](https://holderbook.com/funds/1963355-caitong-international-asset-management-co-ltd/) | $15 | 5 | 0.0% | 1 |
| [RHUMBLINE ADVISERS](https://holderbook.com/funds/1115418-rhumbline-advisers/) | $8 | 3 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 8 | $48.1K |
| Q1 2026 | 8 | $228.1K |
| Q4 2025 | 8 | $692.9K |
| Q3 2025 | 4 | $55.8K |
| Q2 2025 | 4 | $17.0K |
| Q1 2025 | 6 | $28.1K |
| Q4 2024 | 4 | $29.3K |
| Q3 2024 | 6 | $87.3K |
| Q2 2024 | 12 | $135.6K |
| Q1 2024 | 5 | $31.3K |
| Q4 2023 | 7 | $169.2K |
| Q3 2023 | 5 | $58.9K |